Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
38.08 USD | +1.02% | -0.05% | +37.81% |
May. 24 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
May. 21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.81% | 2.89B | |
+17.60% | 124B | |
+15.82% | 109B | |
-6.86% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-8.09% | 16.61B | |
-37.63% | 16.43B | |
+2.39% | 13.4B | |
+25.48% | 11.47B |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- Truist Securities Downgrades PTC Therapeutics to Hold From Buy, Price Target is $25